EXERMET GM FORTE 2 (Glimepiride (2mg) + Metformin (1000mg))

Product Description

Exermet GM Forte 2 Tablet PR is classified as an anti-diabetic medication that combines two active ingredients to manage type 2 diabetes mellitus in adult patients. It plays a crucial role in regulating blood glucose levels in individuals diagnosed with diabetes. To maximize its effectiveness, it is advised to take the tablet in conjunction with meals and to maintain a consistent dosing schedule each day. A healthcare provider will determine the appropriate dosage for each patient, which may be adjusted over time based on the patient’s response and blood sugar readings. Continuation of this treatment is essential even if the patient feels well or experiences stable blood sugar levels. Discontinuing the medication without professional guidance could lead to elevated blood sugar levels, which in turn increases the risk of severe complications such as kidney impairment, vision loss, nerve damage, and potential limb loss. It is important to incorporate a comprehensive treatment approach that includes a nutritious diet, consistent physical activity, and weight management as recommended by a healthcare professional. Lifestyle choices significantly influence the management of diabetes. The primary adverse effect associated with Exermet GM Forte 2 Tablet PR is the risk of hypoglycemia, characterized by low blood sugar levels. Patients are encouraged to familiarize themselves with the symptoms of hypoglycemia—such as sweating, dizziness, headaches, and tremors—and to have quick sources of glucose readily available. Alcohol consumption can heighten the risk of experiencing low blood glucose and is best avoided. Other potential side effects include alterations in taste, nausea, diarrhea, abdominal discomfort, headaches, and respiratory tract infections. Weight gain may also be observed in some individuals while on this medication. Patients should not use this medication if they have type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver dysfunction. It is essential to inform a healthcare provider if there is a history of heart disease or if the patient is pregnant or breastfeeding, as both conditions require careful consideration before initiating treatment. Regular monitoring of blood glucose levels is recommended, and healthcare providers may also conduct tests to assess blood cell counts and liver function during treatment.